Rare Disease Day: The UK’s post-Brexit take on Article 3(d) SPC and its impact on or...
Read more >
Featured Insights: CJEU
DRUGS VS MEDICAL DEVICES – Imbalances in European IP protection
Read more >
Systematic arrangement of colour combinations transported to the CJEU
Read more >
Ferrari race ahead after encouraging judgement from the CJEU
Read more >
Seeing Article 3(d) with 2020 vision – revisited
Read more >
The slow death of Neurim – will SPCs for new indications soon be a thing of the past...
Read more >
Interpreting Article 3(a) of supplementary protection certificates (SPCs) regulation with ...
Read more >
A Whistlestop Guide to SPCs
Read more >
CJEU answers UK reference arising from the UK High Court litigation between Sky and SkyKic...
Read more >
Seeing Article 3(d) with 2020 vision
Read more >
Option is a failure with combination SPCs
Read more >
UK rights can still be enforced in EU, in spite of the triggering of Brexit
Read more >
CJEU rules that mutated organisms are covered by the GMO Directive
Read more >
Louboutin’s infamous red sole trade mark not considered to fall within the shape exclusi...
Read more >